Proteção de Dados (LGPD) Resultados de Exames
Preparo de Exames
  • Exames de sangue
  • Exames de imagem
Mario Penna

DOE AGORA
  • O que fazemos
    • Associações Voluntárias
    • Convênios
    • Comitê de Ética em Pesquisa
    • Direção
    • História
    • Missão, visão e valores
    • Qualidade e segurança
    • Residência e Especialização
    • Unidades
  • Notícias
  • Transparência
    • Compras e Licitações
      • Regulamento
      • Manual do Fornecedor
      • Cadastro SEI Externo
      • Aquisições
        • Hospital Luxemburgo
        • Hospital Regional de Teófilo Otoni
        • Hospital Raja
        • Hinova
    • Nossos Dados
      • Produção
      • Capacidade Instalada
      • Composição da Equipe Assistencial
    • Compliance
      • Programa de Ética e Compliance
      • Código de Conduta
      • Vídeos
    • Demonstrativos Financeiros
    • Editais e Documentos
    • Troco Solidário
    • Relatório de Igualdade Salarial
    • Relatórios e Planejamento
    • Revistas
    • Instrumentos de Repasse / Emendas
  • Trabalhe Conosco
  • Fale Conosco
    • Ouvidoria
    • Canal de Denúncias
    • Solicitação de Benchmarking
  • Como Ajudar
  • —-
  • Hospital Luxemburgo
  • Portal do Câncer
  • Casa de Apoio Beatriz Ferraz
  • Instituto de Ensino, Pesquisa e Inovação
DOE AGORA

HOSPITAL LUXEMBURGO

NEXS I NÚCLEO DE EXCELÊNCIA EM SAÚDE

NÚCLEO DE ENSINO, PESQUISA E INOVAÇÃO

Notícias de: General News

5nov2021
Autor Marketing Categorias Board of Directors, General News

Visit to the Senate guarantees investments for the Mário Penna Institute

Visit to the Senate guarantees investments for the Mário Penna Institute

Instituto Mário Penna is very proud of its partners and, as a Philanthropic Institution, it establishes fundamental cooperation with the Government to offer the best treatment to patients and achieve structural and technological improvements.
Yesterday in Brasília, the CEO of Instituto Mário Penna, Marco Antônio Viana Leite, received confirmation of investments via parliamentary amendments. The amount of R$4 million was confirmed in a visit to the President of the Congress, Senator Rodrigo Pacheco and by Senator Alexandre da Silveira.
In conversation with the parliamentarians, the manager presented the strategic recovery plan that has been executed since he took over the entity in 2019, overcoming major challenges and overcomes in this trajectory. The performance has been strongly based on the institutional strategic objectives in force, which are focused on assistance and economic-financial recovery, on the increase in production and hospital revenue, and on the renegotiation of outstanding debts – bank and with suppliers.
The senators showed recognition for the work Mário Penna, which completed 50 years in June 2021, being a true heritage of Minas Gerais and a reference in cancer care in the state. They were promptly sensitized to the demands presented for renovations and investment in new equipment. “Count on me and Senator Rodrigo Pacheco. The funding is being released to reinforce the service, especially for SUS users throughout the state who are served in Mário Penna”, said Senator Alexandre da Silveira, promising to return the visit soon, to closely monitor the application of resources.

5nov2021
Autor Marketing Categorias Board of Directors, General News

ALMG allocates R$ 5 million from Vale’s repair agreement to Instituto Mário Penna

The Mário Penna Institute will receive R$ 5 million in funding from the Legislative Assembly of Minas Gerais (ALMG), resulting from the State’s agreement with Vale to repair damages resulting from the rupture of the Brumadinho dam. The announcement was made on the afternoon of Friday, August 13, at a ceremony in the plenary, under the command of the President of the House, Deputy Agostinho Patrus.

Marco Antônio Viana Leite speaks at ALMG

The CEO of Instituto Mário Penna, Marco Antônio Viana Leite, was present at the event and, during his speech, highlighted the importance of this resource. “We are a philanthropic institution and we need donations to serve our patients with quality and in a humane way. More than 260 thousand people visit our institution each year, coming from all corners of Minas Gerais. We serve more than 600 municipalities that refer their residents for cancer treatment at the Institute, including the cities affected by the Brumadinho disaster.
It is important to highlight that, after the dam collapsed, analyzes point to an increase in the records of cancer patients in these locations as a result of exposure to water contaminated by heavy metals. Therefore, this resource will be of great value at this time for the purchase of medicines and to provide improvements in patient care”.

Classified by the Ministry of Health as a High Complexity Oncology Care Center (CACON), in 2020 the Mário Penna Institute also carried out 272 thousand radiotherapy applications, 34 thousand chemotherapy sessions, 55 bone marrow transplants and almost 11 thousand surgeries. In addition, it is at the forefront in the fight against Covid-19 and, for this, infirmary beds and other new ICU beds were created, aimed at treating patients with the disease.

The donation – The donation made by ALMG totals R$ 84.5 million and covers social assistance programs, health institutions and support for the production process of the vaccine against Covid-19. In addition to the CEO of Instituto Mário Penna, Marco Antônio Viana Leite, representatives of other benefited entities also attended the ceremony such as the dean of UFMG, professor Sandra Regina Goulart Almeida, representatives of the Rede Cuidar Program, the Bolsa Reciclagem Program, of the Hospital da Baleia and the Intersectorial Committee for Monitoring and Monitoring the State Policy for the Homeless Population (PopRua-MG).

5nov2021
Autor Carolina Farah Categorias General News, Multidisciplinary meeting

Multidisciplinary meetings bring together clinical staff to improve patient care

The Mário Penna Institute’s Medical Residency Committee (COREME) has been holding virtual Multidisciplinary Meetings with the aim of promoting discussions of clinical cases attended at the institution and, thus, providing the physicians with updates.

According to Dr. Ellias Lima, oncologist and Coordinator of COREME, the objective is to bring the clinical staff together, promote medical residency, plan treatments in a multidisciplinary way, update and promote knowledge. The meeting is online on a remote digital platform and involves resident physicians, assistant physicians and preceptors. They take place once a month, with educational support from the pharmaceutical industry.

The last meetings were on the following topics:

– 07/27: “Polytreated castration-resistant metastatic prostate cancer, state of the art in 2021, with the participation of Dr. Ellias Lima (Oncology Coordinator at IMP), Dr. Ana Carolina Pimenta (Oncologist at IMP) and Dr. Marta Rezende (Nuclear Physician at IMP). The meeting was supported by the Astrazeneca laboratory.

– 04/08: “Update on the treatment of advanced platinum sensitive ovarian cancer”, with the participation of Dr. Bárbara Marques (Clinical Oncologist at IMP), Dr. Suellen Peixoto (Gynecological Surgeon at IMP), Dr. Irsael Vilaça (Oncologist at IMP) and Dr. Oscar Araújo (Diagnostic Coordinator at Astrazeneca). Her meeting was supported by the Astrazeneca laboratory.

Instituto Mário Penna invests in the improvement of its clinical staff to increasingly provide a humanized, recognized and excellent service to its thousands of cancer patients.

5nov2021
Autor Marketing Categorias General News, Teaching and Research Center (NEP)

NEP: understand the relationship of mutations to cancer

Genetic mutations can lead to the development of cancer and research shows that 66% of those that cause tumors are random, only 29% are linked to environment or lifestyle and only 5% are linked to heredity. But, do you know what mutations are?

All living beings have genetic material that is responsible for generating the organism and keeping it functioning. This genetic material works like a code that needs to be read and interpreted whenever a biological activity is needed in this organism. Each species has a genetic code that is its own and that is the same among all individuals of that species. However, each individual has small differences that distinguish them from each other. It happens to all of us too. We have the same genetic code, but each has small differences that make us different even when compared to our brothers.

When our cells are going to multiply, whether to repair damaged tissue or to replace other cells, this genetic code needs to duplicate itself. This is important so that each new cell has the same genetic information as the one that originated it. During this duplication step, small errors can happen in the genetic code and they are called mutations.

Most mutations that occur are corrected or the cell is destroyed. However, some cells with mutations can remain in the body. Some of these mutations can bring advantages to living beings and this type of mutation is one of those responsible for the evolution of living beings, that is, they are legal. But some can be quite problematic and can cause serious problems, like those that trigger cancer.

Identifying these mutations is essential to understand the characteristics of the disease and propose increasingly individualized treatment methodologies, thus helping patients to have a more efficient response to available treatments and, consequently, to have a greater chance of cure. In addition, knowledge of mutations in tumors can also identify new types of treatment.

“Working at the frontier of knowledge and research on cancer and with the purpose of expanding this scientific knowledge, proposing solutions for the diagnosis and treatment of cancer patients, researchers from the Translational Research Laboratory of the Teaching and Research Center (NEP), are developing studies to assess the burden of mutations present in patients with breast and ovarian cancer; says Dr. Fábio Queiroz, one of the Laboratory’s researchers. The methodology applied in these surveys was developed by Qiagen™, an internationally renowned company in the production of biotechnology inputs.

*Text written by Dr. Fábio Ribeiro Queiroz

5nov2021
Autor Marketing Categorias Board of Directors, General News

Instituto Galo makes donations to Mário Penna

On July 9, Instituto Galo and Auto Truck delivered 450 sweaters, 1,000 socks and 300 double blankets to Instituto Mário Penna. The action is part of the “Donate Protection” campaign, which aimed to collect cold items for the institution’s patients.

Marco Antônio Viana Leite, President of Instituto Mário Penna, received the delivery during a visit to the institute by the president of Clube Atlético Mineiro, Sérgio Coelho, the president of Instituto Galo, Maria Alice Melo Coelho, the CEO, Thiago Camargo and the former player Reinaldo.

They got to know the Mário Penna Memorial, recently launched in the 50th anniversary of Mário Penna, telling the history of the institution through the walls of the Hospital Luxemburgo. Then, they went to Espaço Benfeitoria, where they received plaques in honor of the important partnership.

Photo: Bruno Souza/Atlético

Along with the team’s mascot, Crazy Cock, the delegation circulated through the hospital’s facilities, talking to collaborators and chemotherapy patients.

“This partnership is extremely important for Mário Penna. We receive patients from all over Minas Gerais. And in this very cold moment, being able to donate warm clothes to those who come from so far away, it’s wonderful. It’s a comfort, a caress in a difficult time of treatment that makes all the difference. I have to thank Atlético Mineiro and Instituto Galo for their support that will provide us with a more welcoming and warm service to patients”; reinforces Marco Antônio Viana Leite.

Instituto Galo is a non-profit association, linked to Clube Atlético Mineiro, dedicated to transforming people’s lives through the love of Galo.

Página anterior 1 … 6 7 8 9 10 … 16 Próxima página

Categorias

  • 50 anos Instituto Mário Penna
  • 50 years IMP
  • Agenda Mário Penna
  • Assistencial
  • BH
  • BH
  • Blog Portal do Câncer
  • Campanhas de Prevenção
  • Cancer Treatments
  • care
  • Casa de Apoio Beatriz Ferraz
  • Cofinho do Bem
  • colaboradores
  • Correios
  • Corrida da Esperança
  • Covid
  • Cuidados Paliativos
  • Curso de Gestão
  • Cursos
  • Dezembro Laranja
  • Dia Internacional da Mulher
  • Diretoria
  • Droga Clara
  • Ensino, Pesquisa e Inovação
  • Entrevista
  • Espaço Mulher
  • Estrelas Mário Penna
  • Fundo do Idoso
  • General News
  • Heróis Mário Penna
  • Histórias de pacientes
  • Histórias de pacientes,Hospital Luxemburgo,Notícias Gerais
  • Histórias de pacientes,Hospital Luxemburgo,Notícias Gerais,Oncologia
  • Histórias de pacientes,Notícias Gerais,Oncologia
  • Hospital Luxemburgo
  • Hospital Luxemburgo,Notícias Gerais,Oncologia
  • Hospital Luxemburgo,Oncologia
  • Hospital Mário Penna
  • Hospital Regional de Teófilo Otoni
  • Humanização
  • Humanization
  • Imposto de Renda
  • Infofarma
  • Instituto Mário Penna
  • Janeiro Branco
  • Julho Verde
  • Linfomas
  • Lista do Bem
  • Lojas Redes
  • Luxembourg Hospital
  • Março Lilás
  • Mario Penna de Todos
  • Maternidade Real
  • Minas na Mesa
  • Momento do Bem
  • Musica no Hospital
  • Não categorizado
  • NEXS
  • Notícias Gerais
  • Notícias Gerais, Oncologia
  • Nova Marca
  • Novembro Azul
  • Novo Hospital Luxemburgo
  • Núcleo de Ensino e Pesquisa (NEP
  • Núcleo de Especialidades Oncológicas (NEO
  • Oncological Treatment
  • Outubro Rosa
  • Parceiros
  • Partners
  • Pastoral da Saúde
  • Pink October
  • Projeto Reintegrar
  • Reunião Multidisciplinar
  • Teaching and Research Center (NEP
  • Teófilo Otoni
  • Todos Juntos Contra o Câncer
  • Tratamento Oncológico
  • Tratamentos Contra o Câncer
  • Verdemar

Assine nossa Newsletter

Fique por dentro de tudo que acontece no Instituto Mário Penna

0800 039 1441

DOAÇÕES POR TELEFONE

SALA DE IMPRENSA

ACESSE POR AQUI

Conecte-se com o Instituto Mario Penna

  • facebook
  • instagram
  • youtube
  • linkedin
Copyright © 2020 Mario Penna. Todos os direitos reservados.CNPJ: 17.513.235/0001-80
Olá, como podemos ajudar?

[cd_calculate_form]

[cd_calculate_form]